Test Price
2,800 AED✅ Home Collection Available
APOE Genotyping (Alzheimer's Disease Type 2) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test result interpretation and risk counseling with a Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS-based genetic test identifies your APOE genotype—ε2/ε3/ε4—the strongest genetic predictor for late‑onset Alzheimer’s disease (type 2). Results empower proactive risk stratification and personalised preventive planning. The test requires mandatory pre‑test genetic counselling to document family history and ensure informed consent as per UAE law.
| Feature | Our Test (NGS) | Closest Alternative (PCR) |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | ~95% (allele dropout possible) |
| Methodology | Full gene sequencing (NGS) | Targeted allele-specific PCR |
| Turnaround | 3–4 weeks | 7–10 days |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics | DHA Registration ID: 9294403): “Understanding your genetic risk for Alzheimer’s can be emotionally challenging; our team emphasises that genetic predisposition is not destiny. Clinical correlation with neurological evaluation and family history is essential. We are here to support you in making informed health decisions under the framework of Federal Decree‑Law No. 4 of 2016 on Medical Liability.”
Medication Advisory
⚠️ Important Notice
Do not discontinue or modify any prescribed medication without consulting your treating physician. This test is a genetic risk assessment tool and does not replace clinical diagnosis, ongoing treatment, or medical advice.
Safety Exclusion Criteria & Urgent Red Flags
- Exclusion: Minors under 18 years without legal guardian consent; individuals unable to provide informed consent; absence of mandatory pre‑test genetic counselling as per Federal Decree‑Law No. 4 of 2016.
- Red Flags: If you experience severe anxiety, depression, or suicidal ideation after receiving results, seek immediate psychological or emergency support.
Patient FAQ & Clinical Guidance
1. What does the APOE genotype test reveal?
This NGS-based test determines your APOE ε2/ε3/ε4 alleles—the strongest genetic markers for late‑onset Alzheimer’s disease risk. The results indicate whether you carry the higher‑risk ε4 variant, which increases susceptibility but does not guarantee development of the disease.
2. Why is genetic counselling mandatory before the test?
UAE law requires pre‑test genetic counselling to ensure you fully understand the implications of APOE results, document your family history, and provide informed consent. Counselling aligns with Federal Decree‑Law No. 4 of 2016 on Medical Liability and promotes responsible use of genetic information.
3. How accurate is the test and what is the turnaround time?
ISO 9001:2015 certified NGS methodology delivers analytical sensitivity and specificity exceeding 99.9%. Results are reported within 3–4 weeks from sample receipt. Turnaround time includes the mandatory counselling session and sequencing analysis.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All test results are encrypted, accessed only by authorised medical personnel, and never shared with third parties without explicit consent. These frameworks guarantee the confidentiality and security of your sensitive genomic information.
Clinical & Logistical Metadata
| Test Name | APOE Genotyping (Alzheimer's Disease Type 2) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Z13.858 |
| LOINC Code | 48818-7 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians